YAYulia Ariani

Yulia Ariani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yulia Ariani has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of MOOC-Based CME on General Practitioners’ Knowledge of Early-Life Nutrition

    by Yoga Devaera, Yulia Ariani, Titis Prawitasari, Diantha Soemantri, Desak Gede Budi Krisnamurti, Rizki Marfira

    General practitioners (GPs) are at the forefront of stunting interventions, but only a few studies have examined their understanding of growth monitoring. Therefore, this study aims to assess the effectiveness of massive open online course (MOOC)-based Continuing Medical Education (CME) programs to increase GPs’ knowledge of nutrition and early detection of growth abnormalities. The study procedures were carried out using a pre- and post-cohort approach involving 121 GPs, mostly working in primary care in Indonesia. The pre- and post-test scores were observed before and after the 12-week MOOC intervention, and the participants were asked for feedback. There were 190 verified participants; the attrition rate was 27.4% (n = 52), and there were six participants with incomplete data, leaving 121 participants as the final sample. The results showed that post-test scores significantly increased after intervention in all domains. These domains included early-life nutrition (7.00 to 9.00), breastfeeding and lactation management (5.56 to 7.78), and feeding problems (7.33 to 8.00) (p < 0.001). Participants reported high satisfaction and preferred a combination of synchronous and asynchronous learning. The feedback suggested improving parental education techniques, specifically in low-socioeconomic settings, and strengthening collaboration between GPs and nutritionists in managing feeding problems.

  • Open Access

    The Genetic Association of Single Nucleotide Polymorphisms of SERPINE1 (rs6092) and IFNAR2 (rs1051393, rs2229207) Genes Is Related to Post Covid-19 Respiratory Syndrome

    by Yulia Ariani, Indra Muhiardi, Indra Gunawan, Nadhifa Tazkia Ramadhani, Shafa Talitha Risti, Riyadi Sutarto, Agus Dwi Susanto

    Background Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2, is a global pandemic. Severe cases may develop post-COVID-19 respiratory syndrome, characterized by symptoms persisting ≥4 weeks. In this study, we aim to identify the association of post-COVID-19 respiratory syndromes with variants in the SERPINE1 and IFNAR2 genes which are responsible for regulating fibrinolysis and immune response against viral infection, respectively. Methods We recalled 85 COVID-19 positive subjects who were originally admitted to Persahabatan Central General Hospital, Jakarta, in 2020—2021. We performed TaqMan genotyping on clinically relevant variants at rs1051393 and rs2229207 in IFNAR2 and rs6092 in SERPINE1 and conducted statistical analysis to identify the association of these variants with the clinical manifestations of post-COVID-19 respiratory syndrome. Results We found that patients with post-COVID-19 respiratory syndrome had greater disease severity at admission (p = 0.02) and during hospitalization (p = 0.004), along with longer hospital stays (p = 0.0001), possibly due to poorer radiological findings at admission (p = 0.013) and discharge (p = 0.001). Variants in SERPINE1 and IFNAR2 showed significant associations: rs1051393 ( IFNAR2 ) with fever (p = 0.037), and rs2229207 with chest pain (p = 0.047), higher potassium (p = 0.001), chloride (p = 0.047), and pCO 2 (p = 0.030). Additionally, rs6092 ( SERPINE1 ) was linked to increased basophils (p = 0.027) and eGFR (p = 0.036). After Benjamini–Hochberg correction, only disease severity during hospitalization (padj = 0.021), radiological findings at admission (padj = 0.052) and discharge (padj = 0.008), hospitalization duration (padj = 0.00016), and the association of rs2229207 with potassium levels (padj = 0.003) remained significant. Conclusion Our findings suggested the potential contribution of genetic predispositions in the SERPINE1 and IFNAR2 genes to the emergence of post-COVID-19 respiratory symptoms, providing additional consideration in treatment management to improve the outcomes of patients positive for COVID-19.

  • Open Access

    Case Report: Integrative Multiomics to Establish Pathogenicity of novel GBE1 R198T Variant

    by Yulia Ariani, Ivan William Harsono, Silvia Tri Widyaningtyas, Cut Nurul Hafifah, Syarifah Dewi, Rina Pratiwi, Beben Benyamin, G Gregory Neely, Dwi Ari Pujianto

    Background Glycogen Storage Disease IV (GSD IV) is a rare disease affecting 1 in every 760,000–960,000 live births. GSD IV is caused by mutations in GBE1 , especially if it affects the central catalytic core domain of the glycogen branching enzyme (GBE) protein at 184 th –600 th residue. A novel missense mutation, GBE1 R198T, was detected in a 3-year-old boy in Indonesia. This variant has not previously been reported in allele frequency databases or classified as pathogenic. Method In this study, we used an integrative multi-omics diagnostic approach involving phenotype analysis, proband and trio genetic mutation analysis, protein molecular modeling, protein-ligand docking, and protein expression studies. We compared GBE1 R198T mutation with the wild-type and previously well-known pathogenic variants, L224P and Y329S, to analyze the clinical progression and pathogenic effects of R198T. Results Trio mutation analysis revealed that this mutation was inherited from a heterozygous parent. Functional prediction, molecular modeling, and docking analysis supported the R198T pathomechanism to cause structural changes in the GBE protein domain, which is detrimental to GBE ligand binding with maltoheptose (Glc7). An in vitro study further supported the decrease in GBE1 R198T protein expression compared to that in the WT. In addition, GBE1 R198T band intensity showed similar results to those of the GBE1 L224 variant, indicating potentially similar pathogenic characteristics exhibited by both variants. Conclusions This is the first study to establish the pathogenicity of the GBE1 R198T variant, and the first rare disease functional study reported in Indonesia.

  • Open Access

    Mutational and Functional Impact of β-globin Gene Mutation in Indonesian Thalassemia Patients using in Silico Method

    by Sri Mufti Ardani, Nadhifa Tazkia Ramadhani, Yulia Ariani, Budi Wiweko, Pustika Amalia Wahidiyat

    Introduction Indonesia is located along the “Thalassemia Belt,” a hotspot region for hemoglobinopathies, including beta thalassemia, with approximately 3–10% of the Indonesian population diagnosed with this disease. Thalassemia was diagnosed using the Hb analysis results. However, the single nucleotide variant (SNVs) database for the Indonesian population, which leads to β-thalassemia disease, has not been extensively studied. This study aimed to profile the genetic variations in Indonesian β-thalassemia patients and conduct in silico characterization of their functional effects. Methods Twenty thalassemia patients were recruited for this study. The sample collected from the respondents was whole blood in EDTA tubes, with a minimum collection time of 14 days after blood transfusion. Genomic DNA (gDNA) was extracted using a commercial kit, directly amplified using Polymerase Chain Reaction (PCR) with specific primers for β-globin and sequenced using Sanger Sequencing. All variants located in exon regions were analyzed using FinchTV, BioEdit, and Biovia Discovery Studio to determine their functional impact. Results Ten reported pathogenic variants were observed along with one rare variant. Genetic variations found according to its common name and nomenclature based on Human Genome Variation Society (HGVS) are IVS1nt.1 (HGVS: c.92+1G>A), IVS1nt.1 (HGVS: c.92+1G>T), IVS1nt.2 (HGVS: c.92+2G>T), IVS1nt.5 (HGVS: c.92+5G>C), IVS2nt.654 (HGVS: c.316-197C>T), Cd15 (HGVS: c.47G>A), Cd26 (HGVS: c.79G>A), Cd30 (HGVS: c.92G>C), Cd41/42 (c.126_129delCTTT), and Cd35 (HGVS: c.110delC). Analysis of amino acid interactions revealed that disease-causing mutations were clinically relevant in each subject. Conclusions This study has bioinformatically proven the effect of genetic mutations and predicted their effect on amino acid interactions. These findings contribute to the study of Indonesian thalassemia and require further research.


  • Open Access

    The Genetic Association of Single Nucleotide Polymorphisms of SERPINE1 (rs6092) and IFNAR2 (rs1051393, rs2229207) Genes Is Related to Post Covid-19 Respiratory Syndrome

    by Yulia Ariani, Indra Muhiardi, Indra Gunawan, Nadhifa Tazkia Ramadhani, Shafa Talitha Risti, Riyadi Sutarto, Agus Dwi Susanto

    Background Coronavirus disease 2019 (Covid-19) is a disease of the respiratory system caused by the SARS-CoV-2 virus. The severity of Covid-19 can be affected by the presence of single nucleotide polymorphisms (SNPs) in certain genes, such as IFNAR2 and SERPINE-1. This study aimed to identify and analyze the presence of SNP rs6092 in the SERPINE1 gene and rs1051393 and rs2229207 in the IFNAR2 gene relation in Covid-19 respiratory syndrome in Indonesia. Methods DNA was isolated from saliva samples of all patients, and a TaqMan Genotyping Assay with a real-time PCR instrument was used to run the samples. The output data were analyzed for demographic data, allele frequency, genotype frequency, and the association of all SNPs with the Covid-19 respiratory syndrome (case) and control subjects. We also analyzed blood laboratory results, blood gas analyses, coagulation factors, and inflammatory factors using SPSS. Results This study included 85 subjects comprise with Covid-19 respiratory syndrome and control subjects. Our study found no association between subjects with Covid-19 respiratory syndrome and any of the variants. However, based on the symptoms caused by rs1051393, we found that it had an effect on fever symptoms. In addition, a significant relationship between rs2229207 and chest pain symptoms was observed in patients with case group. Furthermore, our study found significant differences (p < 0.05) in several blood laboratory analyses, such as the level of basophils and eGFR for rs6092 and the potassium level for rs2229207. Furthermore, arterial blood gas analysis showed that pCO2 and pH levels were significantly different for rs2229207. Conclusion Our study found an association between rs1051393 and fever and between rs2229207 and chest pain in patients with post Covid-19 respiratory syndrome.

  • Open Access

    Clinical phenotype and trio whole exome sequencing data from a patient with glycogen storage disease IV in Indonesia

    by Ivan William Harsono, Yulia Ariani, Beben Benyamin, Fadilah Fadilah, Dwi Ari Pujianto, Cut Nurul Hafifah, Titis Prawitasari


  • Open Access

    Genome-Wide Association Study for the Identification of Genetic Variants Associated with Facial Skin Phenotypes

    by Rusma Yulita, Yulia Ariani Aswin, Rafika Indah Paramita

    Facial skin phenotypes such as pigmentation, wrinkles, and lentigines are determined by genetics and environmental factors. The genetic factor is known as the basic formation of facial skin phenotype variations in different populations. Genetic variations can be used as an approach to understanding genetic influences on the phenotype of interest and may influence molecular and cellular mechanisms. Genome wide-association study (GWAS) is used to identify common genetic variants associated with quantitative traits or complex human diseases. GWAS reveals a single phenotypic which is associated with a large number of SNPs and provides statistical information as significant SNPs. To perform GWAS analysis, bioinformatics tools are used as a rapid genetic data computation for large biological datasets which can report gene/locus with a related biological function viewed in silico. In this review, we summarize a common step-by-step workflow to conduct GWAS using bioinformatics analysis. The step-by-step workflow helps researchers understand how to identify SNPs with phenotypes of interest using bioinformatics approaches. Then, we explore common SNP and gene of facial skin phenotypes from several populations originating from various countries that can provide insights into the genetic contributions to facial skin phenotypes.


  • Open Access

    IDeRare: a lightweight and extensible open-source phenotype and exome analysis pipeline for germline rare disease diagnosis

    by Ivan William Harsono, Yulia Ariani, Beben Benyamin, Fadilah Fadilah, Dwi Ari Pujianto, Cut Nurul Hafifah

    Objectives: Diagnosing rare diseases is an arduous and challenging process in clinical settings, resulting in the late discovery of novel variants and referral loops. To help clinicians, we built IDeRare pipelines to accelerate phenotype-genotype analysis for patients with suspected rare diseases. Materials and Methods: IDeRare pipeline is separated into phenotype and genotype parts. The phenotype utilizes our handmade Python library, while the genotype part utilizes command line (bash) and Python script to combine bioinformatics executable and Docker image. Results: We described various implementations of IDeRare phenotype and genotype parts with real-world clinical and exome data using IDeRare, accelerating the terminology conversion process and giving insight on the diagnostic pathway based on disease linkage analysis until exome analysis and HTML-based reporting for clinicians. Conclusion: IDeRare is freely available under the BSD-3 license, obtainable via GitHub. The portability of IDeRare pipeline could be easily implemented for semi-technical users and extensible for advanced users.


  • Open Access

    IMPACT OF NUTRITIONAL SUPPLEMENTATION ON ENVIRONMENTAL ENTERIC DYSFUNCTION (EED) IN CHILDREN LIVING IN RURAL AREAS: A SYSTEMATIC REVIEW

    by Rizky Abi Rachmadi, Yulia Ariani, Fatima Safira Alatas

    Background: A staggering 99% of infant undernutrition mortality comes from Sub-Saharan Africa and South Asia. Despite multiple interventions focusing on nutrition adequacy, 2.7 million children worldwide remain associated with undernutrition-related mortality. The lack of impact from multiple interventions toward undernutrition reflects a strong reason to believe that EED is the missing link that sustains undernutrition in low-to-middle-income countries (LMICs). EED is a sub-clinical condition caused by repeated oral enteropathogenic and non-pathogenic fecal microbes exposure that causes intestinal villous malformation, multi-omics changes, chronic intestinal and systemic inflammation, and gut dysbiosis. EED impacts the absorptive capacity and the integrity of the gut, causing a cycle of undernutrition in children. There is currently no protocol for the diagnosis and treatment of EED, hence EED is widely believed to be highly prevalent and underdiagnosed in LMICs. Objective: To our knowledge, this is the first systematic review to study the impact of nutritional interventions on EED. Previous studies yielded inconsistent results, hence the synthesis of this information is essential in attaining a deeper understanding of EED to formulate new targets of intervention against child undernutrition. Methods: This systematic review is registered to PROSPERO (CRD42022363157) in accordance to PRISMA, using keywords referring to nutrient supplementation, EED, and child growth failure. Results: Eleven articles were eligible for review, comprising randomized controlled trials performed mainly in the African continent, with a total of 5689 healthy children eligible for analysis. Conclusion: The systematic review illustrates that nutritional interventions have a minimal impact on EED biomarkers and linear growth and reflects the importance of understanding better the mechanisms causing EED and its consequences. It appears that the anabolic contribution of nutrition intervention to child growth is negated by EED.


  • Open Access

    Genetics and genomic medicine in Indonesia

    by Yulia Ariani, Purnomo Soeharso, Damayanti R. Sjarif

    Genetics and genomic medicine in Indonesia.